S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
TMCI · Treace Medical Concepts, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Treace Medical Concepts, Inc (TMCI)
NASDAQ NMS - GLOBAL MARKET
Health Care
$4.13
+0.06
(+1.60%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$4.13
$4.02
$4.13
52-WEEK RANGE
$4.13
$1.17
$7.08
What's happening
- TMCI is up 1.60% today, trading at $4.13. — Live quote
- Volume today (16,880) is well below its 3-month average of 493,390. (Finnhub fundamentals)
- Reports earnings on 2026-11-10 (after market close), 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.24 actual vs. $-0.30 estimated (+21.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 1
Hold 5
Sell 2
Strong sell 2
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
TMCI
+66.12%
vs S&P 500
+53.35%
1-YEAR RETURN
TMCI
-40.15%
vs S&P 500
-54.71%
6-MONTH RETURN
TMCI
+117.65%
3-MONTH RETURN
TMCI
-3.78%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.24
Est. $-0.30
BEAT +21.1%
2026-04-26 (Q1 2026)
$-0.28
Est. $-0.31
BEAT +10.9%
2026-01-26 (Q4 2025)
$-0.15
Est. $-0.15
BEAT +2.0%
2025-10-26 (Q3 2025)
$-0.26
Est. $-0.29
BEAT +9.0%
Valuation Measures & Ratios
Enterprise Value4$315.8M
Forward P/E5—
PEG Ratio6-0.25
Price / Sales (TTM1)1.31
Price / Book73.81
EV4 / Revenue1.54
EV4 / EBITDA—
Profit Margin-28.99%
Operating Margin-27.50%
Return on Equity (ROE8)-74.06%
Return on Assets (ROA9)-31.64%
Avg Volume (3M)493,390
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $261.2M | $86.0M | $420.7M | $366.0M | $535.0M |
| P/E | -3.87 | -1.27 | -6.48 | -5.24 | -7.52 |
| Price/Sales | 1.37 | 0.44 | 2.15 | 1.93 | 2.77 |
| Price/Book | 3.86 | 1.11 | 4.72 | 3.75 | 5.08 |
| EV/Revenue | 1.62 | 0.68 | 2.40 | 2.18 | 2.98 |
| EV/EBITDA | -5.44 | -2.36 | -8.77 | — | — |
| ROE | -99.68% | -87.53% | -72.84% | -71.59% | -67.56% |
| ROA | -37.29% | -36.70% | -33.05% | -33.85% | -34.57% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,976,907
Change from Prior Settlement+13.84%
% of Float—
Days to Cover (Short Ratio)8.60
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-02; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -4.2% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -29.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -40.1%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TMCI
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.4M | $47.2M | $50.2M | $47.4M | $52.6M | $45.1M | $44.5M | $51.1M |
| Gross profit | $35.6M | $37.4M | $39.7M | $37.8M | $41.9M | $36.1M | $35.7M | $41.0M |
| Operating income | -$15.0M | -$17.2M | -$15.7M | -$17.0M | -$15.6M | -$15.1M | -$21.4M | -$19.0M |
| Net income | -$15.9M | -$18.0M | -$16.3M | -$17.4M | -$15.9M | -$15.4M | -$21.2M | -$18.7M |
| EPS (diluted) | $-0.24 | $-0.28 | $-0.26 | $-0.28 | $-0.25 | $-0.25 | $-0.34 | $-0.30 |
| EPS (basic) | $-0.24 | $-0.28 | $-0.26 | $-0.28 | $-0.25 | $-0.25 | $-0.34 | $-0.30 |
| Operating margin | -$33 | -$36 | -$31 | -$36 | -$30 | -$34 | -$48 | -$37 |
| Net margin | -$35 | -$38 | -$32 | -$37 | -$30 | -$34 | -$48 | -$37 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $181.1M | $184.1M | $190.6M | $196.6M | $206.4M | $205.8M | $217.1M | $212.9M |
| Total liabilities | $113.3M | $106.9M | $103.2M | $107.4M | $108.8M | $100.5M | $104.2M | $108.0M |
| Stockholders' equity | $67.7M | $77.2M | $87.3M | $89.2M | $97.6M | $105.3M | $112.9M | $104.9M |
| Total current assets | $120.5M | $123.5M | $132.1M | $138.0M | $147.6M | $149.4M | $161.4M | $157.6M |
| Total current liabilities | $41.5M | $34.5M | $30.6M | $40.9M | $41.9M | $33.2M | $34.9M | $38.3M |
| Cash & equivalents | $12.6M | $9.5M | $10.7M | $7.7M | $8.1M | $13.4M | $11.3M | $12.1M |
| Marketable securities (current) | $33.0M | $42.3M | $37.7M | $49.7M | $61.2M | $62.7M | $64.3M | $70.7M |
| Accounts receivable | $28.7M | $30.4M | $42.2M | $33.0M | $30.3M | $31.1M | $40.8M | $24.2M |
| Inventory | $39.5M | $36.4M | $36.0M | $41.4M | $42.4M | $37.9M | $39.3M | $43.6M |
| Property, plant & equipment | $32.5M | $32.1M | $29.8M | $30.0M | $29.7M | $27.1M | $26.0M | $25.2M |
| Goodwill | $12.8M | $12.8M | $12.8M | $12.8M | $12.8M | $12.8M | $12.8M | $12.8M |
| Intangible assets | $6.7M | $6.9M | $7.1M | $7.4M | $7.6M | $7.8M | $8.1M | $8.3M |
| Other non-current assets | $1.5M | $1.5M | $1.2M | $614.0K | $676.0K | $387.0K | $407.0K | $458.0K |
| Accounts payable | $16.1M | $13.5M | $6.7M | $16.1M | $20.0M | $13.2M | $10.5M | $18.6M |
| Accrued liabilities | $6.3M | $6.0M | $5.8M | $7.3M | $6.2M | $6.0M | $7.2M | $8.1M |
| Short-term debt | $3.2M | $1.8M | $1.7M | $1.8M | $1.1M | $45.0K | $0 | — |
| Long-term debt | $56.0M | $55.8M | $55.6M | $53.5M | $53.5M | $53.4M | $53.3M | $53.2M |
| Other non-current liabilities | $2.7M | $3.0M | $3.0M | $37.0K | $37.0K | $37.0K | $37.0K | $37.0K |
| Common stock & paid-in capital | $65.0K | $65.0K | $64.0K | $64.0K | $63.0K | $63.0K | $62.0K | $62.0K |
| Retained earnings | -$282.8M | -$267.0M | -$249.0M | -$239.6M | -$223.3M | -$205.9M | -$190.0M | -$189.5M |
| Accumulated other comprehensive income (loss) | -$52.0K | -$26.0K | $72.0K | $83.0K | $50.0K | $57.0K | $97.0K | $191.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.7M | $7.2M | -$8.0M | -$9.1M | -$3.0M | $4.2M | -$4.2M | -$11.8M |
| Investing cash flow | $7.1M | -$7.8M | $9.7M | $8.7M | -$3.3M | -$1.9M | $3.4M | $5.8M |
| Financing cash flow | $696.0K | -$588.0K | $1.4M | -$10.0K | $987.0K | -$282.0K | $26.0K | $8.0K |
| Free cash flow | -$6.9M | $4.2M | -$10.4M | -$11.9M | -$7.8M | $655.0K | -$7.3M | -$14.7M |
| Capital expenditures | $2.2M | $3.1M | $2.4M | $2.8M | $4.8M | $3.5M | $3.1M | $2.9M |
| Depreciation & amortization | $1.9M | $899.0K | $2.8M | $2.8M | $2.6M | $2.5M | $2.2M | $2.2M |
| Share-based compensation | $6.5M | $8.0M | $7.6M | $8.0M | $9.6M | $8.7M | $8.6M | $7.9M |
| Change in accounts receivable | -$1.5M | -$11.7M | $9.5M | $2.6M | -$696.0K | -$9.3M | $17.2M | -$1.2M |
| Change in inventory | $3.2M | $335.0K | -$5.4M | -$973.0K | $4.5M | -$1.3M | -$4.4M | $2.3M |
| Change in accounts payable | $2.5M | $6.8M | -$9.4M | -$3.9M | $6.7M | $2.7M | -$8.1M | $576.0K |
| Purchases of investments | $2.6M | $16.1M | $5.7M | $4.6M | $15.2M | $15.1M | $18.7M | $24.2M |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $26.0K | $207.0K | $75.0K | $412.0K | $14.0K | $401.0K | $31.0K | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $212.7M | $209.4M | $187.1M | $141.8M | $94.4M |
| Gross profit | $169.8M | $168.3M | $151.9M | $116.3M | $77.5M |
| Operating income | -$54.2M | -$55.7M | -$51.4M | -$34.8M | -$16.5M |
| Net income | -$59.0M | -$55.7M | -$49.5M | -$42.8M | -$20.6M |
| EPS (diluted) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 |
| EPS (basic) | $-0.93 | $-0.90 | $-0.81 | $-0.77 | $-0.43 |
| Operating margin | -$25 | -$27 | -$27 | -$25 | -$17 |
| Net margin | -$28 | -$27 | -$26 | -$30 | -$22 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $190.6M | $217.1M | $251.9M | $159.0M | $140.8M |
| Total liabilities | $103.2M | $104.2M | $114.0M | $98.5M | $47.7M |
| Stockholders' equity | $87.3M | $112.9M | $137.9M | $60.5M | $93.1M |
| Total current assets | $132.1M | $161.4M | $198.4M | $133.4M | $138.0M |
| Total current liabilities | $30.6M | $34.9M | $45.0M | $30.2M | $18.2M |
| Cash & equivalents | $10.7M | $11.3M | $13.0M | $19.5M | $105.8M |
| Marketable securities (current) | $37.7M | $64.3M | $110.2M | $61.8M | $0 |
| Accounts receivable | $42.2M | $40.8M | $38.1M | $29.2M | $18.6M |
| Inventory | $36.0M | $39.3M | $29.2M | $19.3M | $10.6M |
| Property, plant & equipment | $29.8M | $26.0M | $22.3M | $15.3M | $2.8M |
| Goodwill | $12.8M | $12.8M | $12.8M | $0 | — |
| Intangible assets | $7.1M | $8.1M | $9.0M | $0 | — |
| Other non-current assets | $1.2M | $407.0K | $146.0K | $146.0K | $0 |
| Accounts payable | $6.7M | $10.5M | $11.8M | $8.7M | $4.1M |
| Accrued liabilities | $5.8M | $7.2M | $10.5M | $6.2M | $4.5M |
| Short-term debt | $1.7M | $0 | — | — | — |
| Long-term debt | $55.6M | $53.3M | $53.0M | $52.7M | $29.4M |
| Other non-current liabilities | $3.0M | $37.0K | $37.0K | $0 | — |
| Common stock & paid-in capital | $64.0K | $62.0K | $62.0K | $55.0K | $45.0K |
| Retained earnings | -$249.0M | -$190.0M | -$134.2M | -$84.7M | -$41.9M |
| Accumulated other comprehensive income (loss) | $72.0K | $97.0K | $163.0K | -$27.0K | $0 |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$16.0M | -$37.2M | -$34.6M | -$30.6M | -$17.2M |
| Investing cash flow | $13.3M | $35.4M | -$81.3M | -$76.5M | -$2.7M |
| Financing cash flow | $2.1M | $160.0K | $109.4M | $20.8M | $107.7M |
| Free cash flow | -$29.5M | -$48.8M | -$46.0M | -$45.5M | -$19.9M |
| Capital expenditures | $13.5M | $11.6M | $11.5M | $14.8M | $2.7M |
| Depreciation & amortization | $10.6M | $8.4M | $5.4M | $2.1M | $685.0K |
| Share-based compensation | $33.8M | $30.6M | $17.4M | $8.1M | $3.4M |
| Change in accounts receivable | $2.1M | $5.7M | $9.3M | $11.0M | $4.2M |
| Change in inventory | -$3.2M | $10.0M | $9.8M | $8.8M | $2.7M |
| Change in accounts payable | -$3.8M | -$1.3M | $3.2M | $4.6M | $1.8M |
| Purchases of investments | $40.6M | $71.6M | $169.9M | $63.4M | $0 |
| Debt issued | — | — | — | $0 | $0 |
| Debt repaid | — | — | $0 | $0 | $1.8M |
| Tax withholding on stock comp | $902.0K | $268.0K | $13.0K | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TMCI as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-01-22 to 2026-09-30
Recent transactions
- Insiders have net bought 427,544 shares over the last 182 days, across 12 purchases and 0 sales.
- Most recent: Elder Scot Michael (Chief Legl & Comp Off, CorpSec) — Tax withholding of 25,457 shares on 2026-09-30.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)427,544 sh(12 txns)
Sales (open market)0 sh(0 txns)
Net Shares+427,544
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Tax withholding | 2026-09-30 | 25,457 |
| Treace John T. | Chief Executive Officer | Open market purchase | 2026-08-24 | 11,000 |
| Scanlan Sean F. | Chief Innovation Officer | Tax withholding | 2026-08-09 | 9,814 |
| Hair Mark | Chief Financial Officer | Tax withholding | 2026-08-09 | 37,102 |
| BAKEWELL JOHN K | Reporting person | Grant / award | 2026-05-19 | 30,000 |
| Kiernan Jane E | Reporting person | Grant / award | 2026-05-19 | 30,000 |
| Berry Lance A | Reporting person | Grant / award | 2026-05-19 | 30,000 |
| Jain Deepti | Reporting person | Grant / award | 2026-05-19 | 30,000 |
| HAMILTON LAWRENCE W | Reporting person | Grant / award | 2026-05-19 | 30,000 |
| Hanna Betsy | Reporting person | Grant / award | 2026-05-19 | 30,000 |
| Guglielmino Gaetano | Chief Commercial Officer | Grant / award | 2026-01-22 | 150,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Tax withholding | 25,457 | $0.00 |
| 2026-08-24 | Treace John T. | Chief Executive Officer | Open market purchase | 11,000 | $4.34 |
| 2026-08-21 | Treace John T. | Chief Executive Officer | Open market purchase | 5,000 | $4.35 |
| 2026-08-20 | Treace John T. | Chief Executive Officer | Open market purchase | 39,944 | $4.44 |
| 2026-08-09 | Scanlan Sean F. | Chief Innovation Officer | Tax withholding | 9,814 | $0.00 |
| 2026-08-09 | Hair Mark | Chief Financial Officer | Tax withholding | 37,102 | $0.00 |
| 2026-08-09 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Tax withholding | 16,253 | $0.00 |
| 2026-06-11 | Treace John T. | Chief Executive Officer | Open market purchase | 22,887 | $4.04 |
| 2026-06-10 | Treace John T. | Chief Executive Officer | Open market purchase | 29,430 | $4.02 |
| 2026-06-01 | Treace John T. | Chief Executive Officer | Open market purchase | 50,000 | $3.56 |
| 2026-05-28 | Treace John T. | Chief Executive Officer | Open market purchase | 61,202 | $3.02 |
| 2026-05-27 | Treace John T. | Chief Executive Officer | Open market purchase | 49,810 | $2.87 |
| 2026-05-26 | Treace John T. | Chief Executive Officer | Open market purchase | 4,508 | $2.79 |
| 2026-05-19 | BAKEWELL JOHN K | Reporting person | Grant / award | 30,000 | $0.00 |
| 2026-05-19 | Kiernan Jane E | Reporting person | Grant / award | 30,000 | $0.00 |
| 2026-05-19 | Berry Lance A | Reporting person | Grant / award | 30,000 | $0.00 |
| 2026-05-19 | Jain Deepti | Reporting person | Grant / award | 30,000 | $0.00 |
| 2026-05-19 | HAMILTON LAWRENCE W | Reporting person | Grant / award | 30,000 | $0.00 |
| 2026-05-19 | Hanna Betsy | Reporting person | Grant / award | 30,000 | $0.00 |
| 2026-05-14 | Treace John T. | Chief Executive Officer | Open market purchase | 61,750 | $2.62 |
| 2026-05-13 | Treace John T. | Chief Executive Officer | Open market purchase | 49,013 | $2.46 |
| 2026-05-12 | Treace John T. | Chief Executive Officer | Open market purchase | 43,000 | $2.17 |
| 2026-04-17 | Hair Mark | Chief Financial Officer | Tax withholding | 11,547 | $0.00 |
| 2026-04-01 | Hair Mark | Chief Financial Officer | Grant / award | 100,000 | $0.00 |
| 2026-03-10 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Tax withholding | 1,675 | $0.00 |
| 2026-03-10 | Scanlan Sean F. | Chief Innovation Officer | Tax withholding | 1,396 | $0.00 |
| 2026-03-10 | Treace John T. | Chief Executive Officer | Tax withholding | 5,021 | $0.00 |
| 2026-03-10 | Hair Mark | Chief Financial Officer | Tax withholding | 3,695 | $0.00 |
| 2026-03-08 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Tax withholding | 175 | $0.00 |
| 2026-03-08 | Scanlan Sean F. | Chief Innovation Officer | Tax withholding | 401 | $0.00 |
| 2026-03-08 | Treace John T. | Chief Executive Officer | Tax withholding | 2,062 | $0.00 |
| 2026-03-08 | Hair Mark | Chief Financial Officer | Tax withholding | 964 | $0.00 |
| 2026-02-10 | Scanlan Sean F. | Chief Innovation Officer | Option exercise | 16,875 | $1.05 |
| 2026-01-22 | Guglielmino Gaetano | Chief Commercial Officer | Grant / award | 150,000 | $0.00 |
| 2026-01-22 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Tax withholding | 9,451 | $0.00 |
| 2026-01-22 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Grant / award | 262,500 | $0.00 |
| 2026-01-22 | Hair Mark | Chief Financial Officer | Tax withholding | 17,037 | $0.00 |
| 2026-01-22 | Hair Mark | Chief Financial Officer | Grant / award | 375,000 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 03:43 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-09 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-09 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-09 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-07 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-01 | 4 | 2026-06-01 | View on SEC.gov → |
| 2026-05-28 | 4 | 2026-05-26 | View on SEC.gov → |
| 2026-05-20 | 8-K | 2026-05-19 | View on SEC.gov → |
| 2026-05-19 | 4 | 2026-05-19 | View on SEC.gov → |
Recent news
Headlines about TMCI (Treace Medical Concepts, Inc.). Links open the publisher — we don’t host full articles.
-
AMN,HLF,PGY,BSBK,FXNC,IMRX,CRMT,MRBK,ORN,TISI,FRST,GRNT,VSTS,RVSB,GEF-B,BCRX,SABR,SHEN,DCGO,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20 -
AMN,PGY,HLF,BSBK,FXNC,IMRX,CRMT,ORN,MRBK,FRST,TISI,GRNT,VSTS,RVSB,GEF-B,SHEN,BCRX,DCGO,SABR,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20 -
AMN,HLF,PGY,BSBK,FXNC,IMRX,CRMT,ORN,MRBK,FRST,TISI,GRNT,VSTS,GEF-B,RVSB,SHEN,BCRX,SABR,DCGO,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20 -
AMN,HLF,BSBK,FXNC,IMRX,MRBK,TISI,FRST,GRNT,TPL,FTHM,VSTS,RVSB,GEF-B,BCRX,SABR,DCGO,SHEN,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20 -
AMN,PGY,HLF,BSBK,FXNC,IMRX,CRMT,ORN,MRBK,TISI,FRST,GRNT,VSTS,GEF-B,RVSB,DCGO,BCRX,SHEN,SABR,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-20 -
TMCI Nov 2026 5.000 call (TMCI261120C00005000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-19 -
AMN,PGY,HLF,BSBK,FXNC,IMRX,CRMT,ORN,MRBK,FRST,TISI,GRNT,VSTS,GEF-B,RVSB,SHEN,SABR,DCGO,BCRX,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-18 -
AMN,HLF,PGY,BSBK,FXNC,IMRX,CRMT,ORN,MRBK,FRST,TISI,GRNT,VSTS,GEF-B,RVSB,BCRX,DCGO,SHEN,SABR,TMCI,NBBK,USCB | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-18
No headlines in this category right now — try “All”.